Click either Title or Publisher to read full publication.

Patient selection for LIVE therapy: From clinical indications to multimodality imaging individual case planning

Paulo Neves MD MSc, Thasee Pillay MD, Lon Annest MD MBA, Kevin van Bladel, Erhard Kaiser MD, Fabian Stahl MD, Thorsten Hanke MD PhD, Martin Swaans MD PhD, Patrick Klein MD, Tobias Ruf MD, Ralph Stephan von Bardeleben MD

Echocardiography. September 2021


Live Procedure For The Treatment Of Ischemic Heart Failure - Current Short And Mid-Term Outcomes

Paulo Neves , Thasee Pillay , Lon Annest , Kevin Van Bladel , Erhard Kaiser , Andrew Wechsler , Patrick Klein , Thorsten Hanke , and Ralph Stephan Von Bardeleben

J Am Coll Cardiol. 77 (18_Supplement_1) 588 - May 2021


Long-Term Results of Hybrid Left Ventricular Reconstruction in the Treatment of Ischemic Cardiomyopathy

Jan Naar, Ivo Skalský, Andreas Krűger, Filip Málek, Kevin Van Bladel, Lon S. Annest, Petr Moučka, Tomáš Mráz, Vivek Y. Reddy & Petr Neužil

Journal of Cardiovascular Translational Research - March 2021


Hybrid transcatheter left ventricular reconstruction for the treatment of ischemic cardiomyopathy

Mauro Biffi , Antonio Loforte , Gianluca Folesani , Matteo Ziacchi , Domenico Attinà , Fabio Niro , Ferdinando Pasquale , Davide Pacini

CDT - Vol 11, No 1 (February 2021)


Minimal access left ventricular reconstruction

Thasee Pillay, Paulo Neves, Federico Benetti, Kevin Van Bladel, Andrew Wechsler, Lon Annest

Journal of Cardiac Surgery – September 11, 2020


Hybrid Left Ventricular Reconstruction for the Treatment of Ischemic Cardiomyopathy: Long-term Results from One Center

J. Naar, I. Skalsky, F. Malek, K. Van Bladel, L. Annest, P. Moucka, A. Kruger, T. Mraz, P. Neuzil

HFA Discoveries - 2020


Early Results of the Revivent TC Procedure for Treatment of Left Ventricular Aneurysm and Heart Failure Due to Ischemic Cardiomyopathy

Yan Wang, Guosheng Xiao, Guoming Zhang, Bin Wang, Zhi Lin, Ho David Saiwha, Hao You, Keke Lai, Maolong Su, Hongmei Wen, Jian Wang, Lon Annest, Gary Tse

Eurointervention - 2020


Left Ventricular Volume Reduction and Reshape – ‘Re‐STICHING’ The Field. Reply

Stefan Anker, Sebastian Kelle, Patrick Klein, Andrew Wechsler, Lon Annest, Horst Sievert, Petr Neuzil

EJHF – May 28, 2020

Less Invasive Ventricular Reconstruction for Ischaemic Heart Failure

Patrick Klein, Stefan D. Anker, Andrew Weschler, Ivo Skalsky, Petr Neuzil, Lon S. Annest, Mauro Bifi, Theresa McDonagh, Christian Frerker, Tobias Schmidt, Horst Sievert, Anthony N. Demaria, Sebastian Kelle

European Journal of Heart Failure – December 3, 2019

Less Invasive Ventricular Enhancement (LIVE) as Potential Therapy for Ischaemic Cardiomyopathy End-Stage Heart Failure

Antonio Loforte , Jacopo Alfonsi , Gregorio Gliozzi, Gianluca Folesani, Mariafrancesca Fiorentino, Mauro Biffi, Giuseppe Marinelli, Roberto Di Bartolomeo, Davide Pacini

Journal of Thoracic Disease – April 2019

Impact of Less Invasive Ventricular Enhancement TM (LIVE TM) Compared to Optimal Medical Therapy on Cardiac Output in Patients with HFrEF – Preliminary Results of a 12-Month Multi-Center CMR Trial

Felix Hennig, Lukas Stoiber, Tomas Lapinskas, Seyedeh Mahsa Zamani, Christoph Klein, Christoph Schmitz, Christoph Knosalla, Lon Annest, David Schickling, Volkmar Falk, Burkert Pieske, Sebastian Kelle

ACC 2019 – Poster - March 2019

Improvement of LV Strain in HFrEF Patients at 12 Months Follow-Up Using the Revivent TM System (BioVentrix) Compared to Patients Treated by OMT– Results From a CMR Multi-Center Trial

Tomas Lapinskas, Christoph Klein, Gianni Pedrizzetti, Lukas Stoiber, Felix Hennig, Christoph Knosalla, Christoph Schmitz, David Schickling, Lon Annest, Burkert Pieske and Sebastian Kelle

Circulation – Volume 138, Abstract 16628 – November 5, 2018

Single Center Experience of a Novel, Interventional Left Ventricular Restoration Therapy

C. Frerker, D. Schewel, H. Alessandrini, R. Bader, F. Kreidel, K.H. Kuck, T. Schmidt

DGK 2018 - Abstract – April 2018

The Last Frontier: Transcatheter Devices for Percutaneous or Minimally Invasive Treatment of Chronic Heart Failure

J. Nijenhuis, L.Sanchis, J. A. S. van der Heyden, P. Klein, B. J. W.M. Rensing, A. Latib, Maisano, J.M. Ten Berg, P. Agostoni, M. J. Swaans

Netherlands Heart Journal – July 24, 2017

Transcatheter Transapical Left Ventricle Remodeling in Ischaemic Cardiomyopathy with Apical Aneurysm Using 3rd Generation 3D Cardiac Computed Tomography Fusion Imaging

Ralph Stephan von Bardeleben, Walter Kasper-König, Efthemidis Sotiriou, Andres Beiras-Fernandez, Christian Friedrich Vahl, Thomas Münzel, Eberhard Schulz

European Heart Journal - Volume 38, Issue 30 – May 11, 2017

Less-Invasive Left Ventricular Reshaping – Short- and Long-term Reduction of Heart Failure Symptoms

C. Schmitz, P. Neuzil, I. Skalsky, L. Labrousse, H. Sievert, C. Frerker, T. Schmidt, K. Kuck, M. Biffi, A. Calafiore, D. Pacini, R. Dibartolomeo, G. Davidavicius, G. Kalinauskas, K. Rucinskas

Moderated poster: Heart Failure Congress 2017 - May 2, 2017

Catheter Ablation of Frequent Ventricular Tachycardia After Interventional Left Ventricular Restoration with the Revivent-TranscatheterTM-System

Christian-Hendrik Heeger, Christian Frerker, Kentaro Hayashi, Tobias Schmidt, Shibu Mathew, Christian Sohns, Lukas Kaiser, Andreas Metzner, Karl-Heinz Kuck, Feifan Ouyang

Wiley Online Library - February 23, 2016


New Transcatheter Treatment of the Dilated Ischaemic Cardiomyopathy with Revivent System

Hernández-enríquez M., Brugaletta S., Castellá M., Gutiérrez-capdet M., Petr N., Davidavicius G., Muneretto C. , Sievert H. , Labrousse L., Pomar J.L., Sabaté M.

Euro PCR 2016 - Abstract


BioVentrix® is a privately held medical device company headquartered in Mansfield, MA, USA.

Our News

Contact Us